PMA device
Shockwave C2 Intravascular Lithotripsy (IVL) Catheter
Shockwave Medical, Inc. · Shockwave Intravascular Lithotripsy System (QMG, Class III) · First FDA decision Feb 2, 2023, newest Feb 2, 2023Coronary artery diseasePeripheral artery disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
7
Naming "Shockwave C2"
MAUDE reports
0
Brand "Shockwave C2", since 2015
PubMed studies
0
Mentioning "Shockwave C2"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Shockwave C2 Intravascular Lithotripsy (IVL) Catheter
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Shockwave C2", any status and sponsor, newest update first.
- Intravascular Lithotripsy in Comparison to Rotational Atherectomy: An Evaluation by OFDIPivotal-lookingActive, not recruiting
University Hospital, Clermont-FerrandAcademic, hospital or other
NCT05394649 · 178 participants (planned) · Start Aug 4, 2022 · Primary completion May 31, 2024
Device: Intravascular Lithotripsy; Rotational Atherectomy · For: Intravascular Lithotripsy; Rotational Atherectomy; OFDI
Sites: Amiens, France; Avignon, France; Besançon, France · 17 sites in all
- AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery DiseaseNot yet recruiting
OPCI Core Laboratories LLCAcademic, hospital or other
NCT07512206 · 200 participants (planned) · Start Apr 1, 2026 · Primary completion Oct 1, 2026
Device: Shockwave C2 Aero Coronary IVL System · For: Coronary Artery Disease (CAD); Coronary Calcification; Coronary Calcified Disease and 1 more
Sites: Thousand Oaks, California; Detroit, Michigan; Neptune City, New Jersey · 8 sites in all
Shockwave Medical, Inc.Not on our public-company list
NCT05966662 · 145 participants · Start Dec 8, 2023 · Primary completion Jan 9, 2025
Device: IVL with Shockwave C2+ 2Hz Coronary IVL Catheter · For: Coronary Artery Disease; Myocardial Infarction
Sites: Huntsville, Alabama; La Jolla, California; Washington D.C., District of Columbia · 18 sites in all
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Shockwave C2", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QMG
484 reports: 100 malfunction, 278 injury, 104 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Shockwave C2"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QMG.
- Shockwave Intravascular Lithotripsy (IVL) System with Shockwave C2 Aero Fly Coronary Intravascular Lithotripsy (IVL) CatShockwave Medical, Inc. · PMA 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.